Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Combined Biosensor Strategy Detects Infectious Pathogens

By LabMedica International staff writers
Posted on 14 Jun 2013
A method has been developed that combines deoxyribozyme technology with gold nanoparticles to give a simple point-of-care (POC) diagnostic technique that can be used in remote settings.

The technique merges the colorimetric coupling of surface plasmons of gold nanoparticles (GNPs) with deoxyribozyme (DNAzyme) signal amplification technology to create a fast and simple detection method for genetic targets with a simple colorimetric readout.

Chemical engineers at the University of Toronto (ON, Canada) implemented a genetic sensing assay in a simple two-step system. More...
In the amplification step, a buffered mix of multicomponent nucleic acid enzymes (MNAzymes) and linkers is added to the sample solution and incubated at 50 °C for one hour. If target sequences are present, they bind and activate the MNAzymes. Each active MNAzyme in turn catalyzes cleavage of multiple linkers, which effectively translates into signal amplification.

Any linkers that remained uncleaved caused aggregation of the corresponding GNP pairs, turning the solution purple. In contrast, linkers cleaved by target-activated MNAzymes were not able to cross-link the associated GNP pairs, and solution remained red. In one test for the pathogen Neisseria gonorrhoeae, the mixtures in the specific detection tubes remained red. Following this method, the scientist successfully detected five targets simultaneously. In addition, the assay with lyophilized components was used to correctly identify gonorrhea, malaria, and hepatitis B virus sequences in a sample mixture that contained three out of the five targets. All RNA-containing Linker DNA strands were obtained from Integrated DNA Technologies (Coralville, IA, USA) in purified lyophilized form and all other DNA sequences were from BioBasic (Markham, ON, Canada).

The authors concluded that the assay can detect multiple genetic sequences in parallel and that it could be easily applied to other nucleic acid targets. The color-based readout does not require any complex equipment and uses stable and cost-effective reagents, making this approach particularly suitable for POC testing. Warren C. W. Chan, PhD, a professor in nanobiotechnology and the senior author, said, “There's been a lot of emphasis in developing simple diagnostics. The question is how do you make it simple enough, portable enough? Gold is the best medium, because it's easy to see. It emits a very intense color." The article was published on March 11, 2013, in the journal Angewandte Chemie.

Related Links:

University of Toronto

Integrated DNA Technologies

BioBasic





Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.